Timing of Coronary Bypass Surgery in Patients Receiving Clopidogrel: The Role of VerifyNow

Kareem Bedeir; Kevin Bliden; Udaya Tantry; Paul A. Gurbel; Elisabeth Mahla

doi:10.1016/j.cjca.2016.01.038

Timing of Coronary Bypass Surgery in Patients Receiving Clopidogrel: The Role of VerifyNow

Kareem Bedeir, Kevin Bliden, Udaya Tantry, Paul A. Gurbel, Elisabeth Mahla

School of Medicine

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

We briefly report for the first time the association between a point of care platelet recovery test and the timing of coronary artery bypass grafting after clopidogrel withdrawal. We observe an association between suggested wait days and platelet recovery unit values that might potentially allow for safe shorter wait times before coronary artery bypass grafting without increased bleeding. Our results represent an observation and should prompt further validation.

Original language	English (US)
Pages (from-to)	724-725
Number of pages	2
Journal	Canadian Journal of Cardiology
Volume	32
Issue number	6
DOIs	https://doi.org/10.1016/j.cjca.2016.01.038
State	Published - Jun 1 2016

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.cjca.2016.01.038

Cite this

@article{2ccbe8fc43ed4f0b959a96ded42ca2cc,

title = "Timing of Coronary Bypass Surgery in Patients Receiving Clopidogrel: The Role of VerifyNow",

abstract = "We briefly report for the first time the association between a point of care platelet recovery test and the timing of coronary artery bypass grafting after clopidogrel withdrawal. We observe an association between suggested wait days and platelet recovery unit values that might potentially allow for safe shorter wait times before coronary artery bypass grafting without increased bleeding. Our results represent an observation and should prompt further validation.",

author = "Kareem Bedeir and Kevin Bliden and Udaya Tantry and Gurbel, {Paul A.} and Elisabeth Mahla",

note = "Funding Information: Dr Gurbel received research grants, honoraria, and consultant fees from Haemoscope, Hemonetics, AstraZeneca, Merck, Medtronic, Lilly/Daiichi Sankyo Inc, Sanofi-Aventis/Bristol Myers, Portola, Novartis, Boston-Scientific, Bayer, Novartis, Accumetrics, Boehringer Ingelheim, and Johnson and Johnson. Publisher Copyright: {\textcopyright} 2016 Canadian Cardiovascular Society.",

year = "2016",

month = jun,

day = "1",

doi = "10.1016/j.cjca.2016.01.038",

language = "English (US)",

volume = "32",

pages = "724--725",

journal = "Canadian Journal of Cardiology",

issn = "0828-282X",

publisher = "Pulsus Group Inc.",

number = "6",

}

TY - JOUR

T1 - Timing of Coronary Bypass Surgery in Patients Receiving Clopidogrel

T2 - The Role of VerifyNow

AU - Bedeir, Kareem

AU - Bliden, Kevin

AU - Tantry, Udaya

AU - Gurbel, Paul A.

AU - Mahla, Elisabeth

N1 - Funding Information: Dr Gurbel received research grants, honoraria, and consultant fees from Haemoscope, Hemonetics, AstraZeneca, Merck, Medtronic, Lilly/Daiichi Sankyo Inc, Sanofi-Aventis/Bristol Myers, Portola, Novartis, Boston-Scientific, Bayer, Novartis, Accumetrics, Boehringer Ingelheim, and Johnson and Johnson. Publisher Copyright: © 2016 Canadian Cardiovascular Society.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - We briefly report for the first time the association between a point of care platelet recovery test and the timing of coronary artery bypass grafting after clopidogrel withdrawal. We observe an association between suggested wait days and platelet recovery unit values that might potentially allow for safe shorter wait times before coronary artery bypass grafting without increased bleeding. Our results represent an observation and should prompt further validation.

AB - We briefly report for the first time the association between a point of care platelet recovery test and the timing of coronary artery bypass grafting after clopidogrel withdrawal. We observe an association between suggested wait days and platelet recovery unit values that might potentially allow for safe shorter wait times before coronary artery bypass grafting without increased bleeding. Our results represent an observation and should prompt further validation.

UR - http://www.scopus.com/inward/record.url?scp=84963538270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963538270&partnerID=8YFLogxK

U2 - 10.1016/j.cjca.2016.01.038

DO - 10.1016/j.cjca.2016.01.038

M3 - Article

C2 - 27094125

AN - SCOPUS:84963538270

SN - 0828-282X

VL - 32

SP - 724

EP - 725

JO - Canadian Journal of Cardiology

JF - Canadian Journal of Cardiology

IS - 6

ER -

Timing of Coronary Bypass Surgery in Patients Receiving Clopidogrel: The Role of VerifyNow

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this